J.P. Morgan Remains Overweight On Danaher (DHR)

J.P. Morgan remained Overweight on Danaher DHR in a research report published today. In the report, J.P. Morgan states, "While large, the BEC deal lines up as well as a deal this size could, an opportunistic purchase that is strategically/financially down the middle. Size is an issue, but is soft/sentiment-related negative, outweighed by the financial potential, in our view. We see DHR shares drifting higher in the coming weeks as the company is already setting up EPS/FCF growth in 2012/2013." Shares of Danaher were at $49.74 at the time of posting in pre-market trading, reflecting no change from Tuesday's market close.